Location: San Francisco, CA
CIK: 0001587114 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $2.356B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AKTS | AKTIS ONCOLOGY INC | 4,824,469 | $86.31M | 3.7% | $17.89 | — | COM ADDED | 01021M104 |
| RLAY | RELAY THERAPEUTICS INC | 1,904,762 | $18.95M | 0.8% | $8.30 | 0.0% | COM | 75943R102 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 410,800 | $16.32M | 0.7% | $32.01 | — | CALL | 152309100 |
| ERAS | ERASCA INC | 900,000 | $14.56M | 0.6% | $10.02 | 0.0% | COM | 29479A108 |
| EIKN | EIKON THERAPEUTICS INC | 732,606 | $7.751M | 0.3% | $10.58 | — | COM ADDED | 282564103 |
| REPL | REPLIMUNE GROUP INC | 1,000,000 | $7.65M | 0.3% | $7.81 | 0.0% | COM | 76029N106 |
| ZURA | ZURA BIO LTD | 1,179,715 | $7.019M | 0.3% | $5.88 | 0.0% | CLASS A ORD SHS | G9TY5A101 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 625,000 | $6.944M | 0.3% | $13.69 | 0.0% | COM | 71722W107 |
| STOK | STOKE THERAPEUTICS INC | 100,000 | $3.256M | 0.1% | $31.83 | 0.0% | COM | 86150R107 |
| PRLD | PRELUDE THERAPEUTICS INC | 947,049 | $3.239M | 0.1% | $2.30 | 0.0% | COM | 74065P101 |
| HLXC | HELIX ACQUISITION CORP III USD | 200,000 | $2.032M | 0.1% | $10.16 | — | CL A ORD SHS ADDED | G4444S107 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CNTA | CENTESSA PHARMACEUTICALS PLC | 6,000,000 (+92.6%) | $238M (+205.9%) | 10.1% | $32.01 | — | SPONSORED ADS | 152309100 |
| CGON | CG ONCOLOGY INC | 1,102,000 (+42.7%) | $74.58M (+132.7%) | 3.2% | $44.69 | +17.3% | COM | 156944100 |
| ETON | ETON PHARMACEUTICALS INC | 2,171,938 (+7.0%) | $53.6M (+56.1%) | 2.3% | $9.47 | +68.9% | COM | 29772L108 |
| MREO | MEREO BIOPHARMA GROUP PLC | 13,368,855 (+70.2%) | $4.412M (+34.8%) | 0.2% | $0.38 | — | SPON ADS | 589492107 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IMNM | IMMUNOME INC | 2,855,590 | $61.34M | 2.6% | $8.38 | +175.4% | — | 45257U108 |
| GPCR | STRUCTURE THERAPEUTICS INC | 334,380 | $23.26M | 1.0% | $69.55 | — | — | 86366E106 |
| PCVX | VAXCYTE INC | 450,000 | $20.76M | 0.9% | $44.73 | +18.0% | — | 92243G108 |
| AQST | AQUESTIVE THERAPEUTICS INC | 2,625,000 | $16.96M | 0.7% | $4.32 | -7.0% | — | 03843E104 |
| VYGR | VOYAGER THERAPEUTICS INC | 4,002,847 | $15.73M | 0.7% | $3.88 | — | — | 92915B106 |
| CGON | CG ONCOLOGY INC | 292,800 | $12.16M | 0.5% | $44.69 | +17.3% | CALL | 156944100 |
| MNKD | MANNKIND CORP | 1,660,000 | $9.412M | 0.4% | $5.51 | +1.1% | — | 56400P706 |
| — | NUVATION BIO INC | 963,333 | $8.631M | 0.4% | $10.45 | — | — | 67080N119 |
| EOLS | EVOLUS INC | 675,000 | $4.489M | 0.2% | $6.77 | -27.7% | — | 30052C107 |
| CAMP | CAMP4 THERAPEUTICS CORP | 325,000 | $1.992M | 0.1% | $4.25 | +9.7% | — | 13463J101 |
| XNCR | XENCOR INC | 67,500 | $1.033M | 0.0% | $32.11 | -60.6% | CALL | 98401F105 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MBX | MBX BIOSCIENCES INC | 777,000 (-63.4%) | $23.19M (-65.4%) | 1.0% | $18.46 | +99.5% | COM | 55287L101 |
| XNCR | XENCOR INC | 2,183,000 (-32.9%) | $26.33M (-47.1%) | 1.1% | $32.11 | -60.6% | COM | 98401F105 |
| ATRA | ATARA BIOTHERAPEUTICS INC | 99,593 (-82.6%) | $471K (-95.5%) | 0.0% | $13.39 | -50.8% | COM NEW | 046513206 |
| IBIO | IBIO INC | 1,583,000 (-28.9%) | $3.008M (-30.1%) | 0.1% | $1.36 | +69.5% | COM NEW | 451033708 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ANAB | ANAPTYSBIO INC | 7,880,094 | $437M | 18.5% | $23.54 | +109.7% | COM | 032724106 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 4,288,120 | $156M | 6.6% | $32.41 | +51.8% | COM | 22663K107 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 1,706,469 | $323M | 13.7% | $120.72 | +40.0% | SHS USD | G50871105 |
| ORIC | ORIC PHARMACEUTICALS INC | 6,728,116 | $85.25M | 3.6% | $15.26 | -29.5% | COM | 68622P109 |
| ZYME | ZYMEWORKS INC | 22,970,388 | $575M | 24.4% | $9.83 | +137.7% | COM | 98985Y108 |
| ZBIO | ZENAS BIOPHARMA INC | 789,500 | $15.43M | 0.7% | $32.89 | -33.5% | COM | 98937L105 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 2,823,126 | $25.27M | 1.1% | $11.58 | — | COM NEW | 107924102 |
| CRSP | CRISPR THERAPEUTICS AG | 1,389,276 | $66.09M | 2.8% | $71.59 | -25.3% | NAMEN AKT | H17182108 |
| GLPG | GALAPAGOS NV | 1,667,119 | $50.01M | 2.1% | $32.49 | — | SPON ADR | 36315X101 |
| NGNE | NEUROGENE INC | 1,271,342 | $25.63M | 1.1% | $14.32 | +26.7% | COM | 64135M105 |
| SRZNW | SURROZEN INC | 4,444 | $129K | 0.0% | $7.07 | — | *W EXP 08/01/203 | 86889P117 |